Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Pain Manag Nurs ; 25(3): e177-e185, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38097467

ABSTRACT

BACKGROUND: Since patients are conscious during the coronary angiography procedure, they may experience pain and anxiety regarding possible complications and an uncertain outcome. AIM: This study was conducted to determine the effects of virtual reality application on pain severity, anxiety level, and patient satisfaction in patients who undergo coronary angiography. METHOD: This randomized controlled study was conducted with a total of 70 patients, including 35 patients in the intervention and 35 patients in the control group. Apart from their routine treatment, virtual reality glasses application was used in the intervention group patients during the procedure. The patients in the control group were given only routine treatment. Data were collected by using "Descriptive Information Form", "Visual Analogue Scale (VAS)", Anxiety Assessment Scale (AAS), "Physiological Symptoms of Anxiety Follow-up Form", and "Virtual Reality Glass Application Satisfaction Form". RESULTS: Mean post-intervention scores of VAS, AAS, heart rate, diastolic and systolic blood pressure, respiratory rate of the intervention group decreased significantly compared with the control group, while O2 saturation value was found to increase significantly. CONCLUSIONS: In this study, it was found that virtual reality application was effective in reducing pain and anxiety, increasing patient satisfaction, and normative regulation of vital signs in patients who undergo coronary angiography.


Subject(s)
Anxiety , Coronary Angiography , Patient Satisfaction , Virtual Reality , Humans , Male , Female , Middle Aged , Anxiety/psychology , Anxiety/etiology , Anxiety/therapy , Coronary Angiography/methods , Coronary Angiography/psychology , Aged , Pain Management/methods , Pain Management/standards , Pain Measurement/methods , Adult , Pain/psychology
2.
J Trace Elem Med Biol ; 80: 127274, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37562273

ABSTRACT

BACKGROUND: Acrylamide (ACR) is a heat-related carcinogen used in cooking some foods as well as in other thermal treatments. The present study aims to investigate the possible protective effect of boron (BA) against ACR-induced toxicity of kidney, brain, heart, testis, and bladder tissues in rats. METHODS: Rats have been divided into 5 equal groups: Control (saline), ACR (38.27 mg/kg), BA (20 mg/kg), BA+ ACR (10 mg/kg + ACR), and BA+ ACR (20 mg/kg BA+ACR). Kidney tissue from rats was collected and the levels of malondialdehyde (MDA), glutathione (GSH), and the activity of superoxide dismutase (SOD) were measured. In addition, the kidneys of these animals, as well as the brain, heart, testes, and bladder tissues were examined for possible histological changes. Total Nrf2 and Keap-1 protein expression in kidney, heart, and testis tissues was examined by immunohistochemistry. RESULTS: While significant increases in MDA levels were observed in the kidneys of rats receiving ACR alone, significant decreases in antioxidant markers (SOD and GSH) were observed. Besides, kidney, brain, heart, and testicular tissues were analyzed and damage was observed in the groups receiving ACR. However, no significant histologic changes were noted in the bladder tissue. Both dosages of BA in combination with ACR improved the changes in ACR-induced antioxidant tissue parameters. Despite the fact that MDA levels were decreased with these two dosages, histological structural abnormalities were found to be greatly improved. CONCLUSION: Our results show that BA has a strong protective effect on ACR-induced multi-organ toxicity. The study results show that BA could be a potential element to reduce ACR toxicity to which we are often exposed.


Subject(s)
Antioxidants , Boron , Male , Rats , Animals , Antioxidants/metabolism , Boron/pharmacology , NF-E2-Related Factor 2/metabolism , Testis/metabolism , Cardiotoxicity/drug therapy , Acrylamide/toxicity , Acrylamide/metabolism , Oxidative Stress , Signal Transduction , Glutathione/metabolism , Superoxide Dismutase/metabolism
3.
Environ Toxicol Pharmacol ; 102: 104218, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37451528

ABSTRACT

Cadmium chloride (Cd) and sodium arsenite (As) are two prominent examples of non-biodegradable substances that accumulate in ecosystems, pose a serious risk to human health and are not biodegradable. Although the toxicity caused by individual use of Cd and As is known, the toxicity of combined use (Cd+As) to mammals is poorly understood. The present study aims to investigate the hepatoprotective effect of curcumin (CUR), a naturally occurring bioactive component isolated from the root stem of Curcuma longa Linn., in preventing liver damage caused by a Cd+As mixture. A group of 30 Sprague-Dawley rats were subjected to intraperitoneal administration of Cd+As (0.44 mg/kg+5.55 mg/kg i.p.) and CUR (100 or 200 mg/kg) for a period of 14 days. The experimental results showed that the animals treated with Cd+As exhibited changes in liver biochemical parameters, inflammation and oxidative stress at the end of the experiment. Administration of CUR significantly reduced inflammation, oxidative stress and lipid peroxidation in the Cd+As plus CUR groups compared to the Cd+As group. Furthermore, histological examination of the liver tissue showed that administration of CUR had led to a significant reduction in the liver damage observed in the Cd+As group. The present study provides scientific evidence for the protective effects of CUR against lipid peroxidation, inflammation, oxidative stress and liver damage induced by Cd+As in the liver of rats. The results of our in vivo experiments were confirmed by those of our molecular modelling studies, which showed that CUR can enhance the diminished antioxidant capacity caused by Cd+As.


Subject(s)
Arsenic , Curcumin , Liver Diseases , Humans , Rats , Animals , Cadmium/metabolism , Curcumin/pharmacology , Arsenic/toxicity , Arsenic/metabolism , NF-kappa B/metabolism , Interleukin-1beta/metabolism , Ecosystem , Rats, Sprague-Dawley , Antioxidants/pharmacology , Antioxidants/metabolism , Oxidative Stress , Liver , Liver Diseases/metabolism , Inflammation/metabolism , Mammals
4.
Can J Physiol Pharmacol ; 100(10): 968-982, 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-36148907

ABSTRACT

Apart from demonstrating the interaction behavior of malondialdehyde (MDA) with Na+/K+-ATPase using in silico, the current study aims to investigate the effect of rheumatoid arthritis-related oxidative stress on Na+/K+-ATPase activity that is present in the erythrocyte cell membrane, which is rich in proteins vulnerable to damage from MDA and other free radicals. The target population of this study consists of 28 rheumatoid arthritis patients and 20 healthy volunteers whose MDA levels and Na+/K+-ATPase activity were determined. It was shown that MDA levels of rheumatoid arthritis patients increased (p < 0.001) and their Na+/K+-ATPase activity noticeably decreased when compared to those of healthy individuals. Also, according to this in silico modeling, MDA decreased Na+/K+-ATPase activity in line with the correlation analyses. Consequently, while elevated levels of MDA in the rheumatoid arthritis group were suggestive of oxidative stress, a decreased Na+/K+-ATPase-activity led us to speculate that the cellular membrane had sustained injury. Therefore, our results could be useful in explaining how MDA affects Na+/K+-ATPase activity in the interior of a specific molecular pathway.


Subject(s)
Arthritis, Rheumatoid , Erythrocyte Membrane , Arthritis, Rheumatoid/metabolism , Erythrocyte Membrane/metabolism , Erythrocytes/metabolism , Humans , Malondialdehyde/metabolism , Sodium/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism
5.
Life Sci ; 307: 120864, 2022 Oct 15.
Article in English | MEDLINE | ID: mdl-35940215

ABSTRACT

INTRODUCTION: This study aims to investigate whether boric acid (BA) can protect rats from acrylamide (AA)-induced acute liver injury. MATERIALS AND METHODS: AA was used to induce acute liver injury. Thirty rats were divided into five group including Group 1 (saline), Group 2 (AA), Group 3 (20 mg/kg BA), Group 4 (10 mg/kg BA+AA) and Group 5 (20 mg/kg BA+AA). Their blood and liver were harvested to be kept for analysis. Liver function enzyme activities were performed by spectrophotometric method. Catalase (CAT), superoxide dismutase (SOD) activity, and malondialdehyde levels were determined by colorimetric method. The in-silico studies were performed using the "blind docking" method. RESULTS: Administration AA to rats, biochemical parameters, liver histology, and expression levels of apoptotic markers were negatively affected. However, after the administration of BA, the altered biochemical parameters, liver histology, and expression levels of apoptotic markers were reversed. Moreover, the mechanisms of AA-induced deterioration in the levels of SOD, CAT, and Nrf2-Keap-1 and the mechanisms of the protective effect of BA against these deteriorations were explained by in silico studies. CONCLUSION: Thus, the present study could explain the interactions between AA and thiol-containing amino acid residues of Keap-1, the effect of BA on these interactions, and the biochemical toxicity caused by the AA. In this sense, this work is the first of its kind in the literature. Based on the biochemical, histopathological, and in silico results, it can be suggested that BA has the potential to be used as a protective agent against AA-induced liver injury.


Subject(s)
Acrylamide , NF-E2-Related Factor 2 , Animals , Rats , Acrylamide/toxicity , Amino Acids/metabolism , Antioxidants/metabolism , Antioxidants/pharmacology , bcl-2-Associated X Protein/metabolism , Boric Acids , Catalase/metabolism , Liver/metabolism , Malondialdehyde/metabolism , NF-E2-Related Factor 2/metabolism , Oxidative Stress , Protective Agents/metabolism , Protective Agents/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction , Sulfhydryl Compounds/metabolism , Sulfhydryl Compounds/pharmacology , Superoxide Dismutase/metabolism
6.
J Biomol Struct Dyn ; 40(17): 7926-7939, 2022 10.
Article in English | MEDLINE | ID: mdl-33779508

ABSTRACT

The present study aims to investigate the substrate (4-methyl catechol and catechol) specificity and inhibition mechanisms (l-ascorbic acid, citric acid, and l-cysteine) of the tyrosinase enzyme (TYR), which is held responsible for browning in foods and hyperpigmentation in the human skin, through kinetic and molecular docking studies. During the experimental studies, the diphenolase activities of TYR were determined, following which the inhibitory effects of the inhibitors upon the diphenolase activities of TYR. The inhibition types were determined as competitively for l-ascorbic acid and citric acid and noncompetitive for l-cysteine. The kinetic results showed that the substrate specificity was better for catechol while l-cysteine showed the best inhibition profile. As for the in silico studies, they also showed that catechol had a better affinity in line with the experimental results of this study, considering the interactions of the substrates with TYR's active site residues and their distance to CuB metal ion, which is an indicator of diphenolase activity. Besides, the inhibitory mechanisms of the inhibitor molecules were explained by the molecular modeling studies, considering the binding number of the inhibitors with the active site amino acid residues of TYR, the number and length of H bonds, negative binding energy values, and their distance to CuB metal ion. Based on our results, we suggest that the novel method used in this study to explain the inhibitory mechanism of l-cysteine may provide an affordable alternative to the expensive methods available for explaining the inhibitory mechanism of TYR and those of other enzymes. HighlightsThe best affinity for the tyrosinase enzyme occurred with catechol.l-Ascorbic acid, citric acid, l-cysteine inhibited the diphenolic activity of tyrosinase.In silico studies confirmed the best affinity shown by catechol.Product inhibition mechanism of l-cysteine explained by in silico for the first time.Communicated by Ramaswamy H. Sarma.


Subject(s)
Agaricales , Monophenol Monooxygenase , Agaricus , Ascorbic Acid , Catechols/pharmacology , Citric Acid/pharmacology , Cysteine , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Guaiacol/pharmacology , Humans , Kinetics , Molecular Docking Simulation , Monophenol Monooxygenase/metabolism
7.
Int Immunopharmacol ; 97: 107654, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33895477

ABSTRACT

Rheumatoid Arthritis (RA) is the most prevalent cause of the systematic inflammatory arthritis that destroys the joints. While the pathogenesis of RA remains to be clarified, the imbalance in the oxidant and anti-oxidant defense system plays a crucial role. This study aims to evaluate oxidant and anti-oxidant levels of RA patients and their impacts on the activity of the disease via in silico studies. 28 patients who had not previously received any treatment for RA and 20 healthy controls were included. Their oxidative stress markers, antioxidant markers, and inflammatory factors were investigated via in silico studies. Compared to the Control Group, serum CRP levels, MDA levels, and XO activities were higher in RA Group. Cu/ZnSOD and GPx activities decreased while CAT activities remained unchanged. Besides, there was a positive correlation between MDA-serum CRP levels but a negative correlation between MDA levels-Cu/ZnSOD activities. Furthermore, we observed a negative correlation between CRP levels and Cu/ZnSOD activities. Based on these results, it was concluded that oxidative stress had increased, the defense system had weakened, and ROS production had increased. Finally, our study results with SOD and CAT activity were confirmed by molecular docking studies.


Subject(s)
Arthritis, Rheumatoid/immunology , Catalase/metabolism , Malondialdehyde/metabolism , Superoxide Dismutase/metabolism , Adult , Antioxidants/metabolism , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/metabolism , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Case-Control Studies , Catalytic Domain , Female , Follow-Up Studies , Healthy Volunteers , Humans , Lipid Peroxidation/immunology , Male , Malondialdehyde/blood , Middle Aged , Molecular Docking Simulation , Oxidants/metabolism , Oxidative Stress/immunology , Reactive Oxygen Species/metabolism
8.
Toxicol Appl Pharmacol ; 411: 115386, 2021 01 15.
Article in English | MEDLINE | ID: mdl-33383042

ABSTRACT

This study aims to investigate whether Escin (ES) can protect against Cyclophosphamide (CPM)-induced cardiac damage. The experimental rats were categorized as Control, CPM (200 mg/kg), ES (10 mg/kg), and CPM + ES Groups, each having 6 members. Their heart tissues were stained with Hematoxylin and Eosin and the structural changes were investigated under the light microscope. The biochemical markers of ischemia modified albumin (IMA), creatine kinase (CK-MB), antioxidant activity indicators Catalase (CAT), and superoxide dismutase (SOD) activities were measured using blood samples. Besides, the effects of CPM, ES, and CPM + ES upon CAT and SOD activities were shown via molecular docking studies. In the Single-Dose CPM group, CK-MB and IMA levels significantly increased while SOD and CAT levels significantly decreased. However, the heart tissues were damaged. CK-MB and IMA levels significantly decreased in CP+ ES Group. On the other hand, SOD, and CAT levels significantly increased and reduced the damage remarkably. Our findings showed that ES treatment successfully reduced the toxic effects upon the rats. The conclusion is that ES treatment can help protect the heart tissue against CPM-induced toxicity. Both in-vivo results and molecular modeling studies showed that the negative effects of CPM upon SOD activity were bigger than that of CAT.


Subject(s)
Antioxidants/pharmacology , Cyclophosphamide , Escin/pharmacology , Heart Diseases/prevention & control , Molecular Docking Simulation , Myocytes, Cardiac/drug effects , Oxidative Stress/drug effects , Animals , Antioxidants/chemistry , Biomarkers/blood , Cardiotoxicity , Catalase/blood , Catalase/chemistry , Creatine Kinase, MB Form/blood , Disease Models, Animal , Escin/chemistry , Heart Diseases/blood , Heart Diseases/chemically induced , Heart Diseases/pathology , Male , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Protein Conformation , Rats, Sprague-Dawley , Serum Albumin, Human , Structure-Activity Relationship , Superoxide Dismutase/blood , Superoxide Dismutase/chemistry
9.
Biochem Biophys Res Commun ; 534: 927-932, 2021 01 01.
Article in English | MEDLINE | ID: mdl-33143874

ABSTRACT

Attention Deficit Hyperactivity Disorder (ADHD) is the most common psychiatric disorder reported particularly in children. Long-term use of antipsychotic drugs used in the treatment of ADHD has been shown to exert toxic effects on the brain. However, not enough research has been carried out on the neurotoxic effects of these drugs on the brain tissue. Atomoxetine (ATX) is the most widely used antipsychotic drug that has gained approval for ADHD treatment. The present study aims to determine the damage induced by long-term use of three different doses of ATX in the brain tissue of experimental rats. 24 rats were divided into Control group (0.5 mL saline), Group 2 (0.5 mg/mL ATX), Group 3 (1.0 mg/mL ATX), and Group 4 (2.0 mg/mL ATX), each group having 6 members. Their brain tissues were taken for stereological, histological, and nuclear factor kappa-B (NF-kB) protein expression analysis. ATX was determined to have caused a few alterations in the brain tissue, such as disruption in the endothelial epithelium of capillaries, a couple of large astrocyte nuclei, and mitotic astrocytes. Moreover, a significant difference was observed in Group 4 compared to Control Group in terms of astrocyte counts in the brain sections. As for Groups 3 and 4, there were differences in terms of oligodendrocyte counts in the incisions cultivated from the brain tissues of the animals. On the other hand, NF-kB positive astrocytes of Groups 3 and 4 differed significantly from those of Control and Group 2. The results of molecular dockings of the present study are in line with the in-vivo results. Therefore, it was concluded that the higher the dose of ATX was, the more damage the brain tissue sustained.


Subject(s)
Adrenergic Uptake Inhibitors/adverse effects , Atomoxetine Hydrochloride/adverse effects , Attention Deficit Disorder with Hyperactivity/drug therapy , Brain/drug effects , NF-kappa B/metabolism , Adrenergic Uptake Inhibitors/therapeutic use , Animals , Atomoxetine Hydrochloride/therapeutic use , Attention Deficit Disorder with Hyperactivity/metabolism , Attention Deficit Disorder with Hyperactivity/pathology , Brain/metabolism , Brain/pathology , Rats , Rats, Wistar
10.
Bioorg Chem ; 105: 104435, 2020 12.
Article in English | MEDLINE | ID: mdl-33161254

ABSTRACT

This study aims to determine whether atomoxetine (ATX), used as an alternative to methylphenidate, affects superoxide dismutase (SOD) activity besides glutathione (GSH) and malondialdehyde (MDA) levels, apart from determining possible effects of ATX on SOD activity through molecular docking studies. 24 male Wistar rats were divided into 4 groups, each containing 6 members. After a 6-week application of ATX, blood samples and brain tissues were obtained from the rats for biochemical analyses. Besides, molecular docking studies were conducted using PyRx and Discovery Studio 3.0 programs. No significant difference occurred in GSH and MDA levels after ATX application. A high-dose application of ATX caused a statistically significant change only in the serum-SOD activity compared to that of Control Group. Molecular docking studies revealed that ATX settled in the biggest space rather than the catalytic regions of Cu2Zn2-SOD. Our biochemical and molecular docking data showed that ATX, an alternative drug to stimulant methylphenidate, showed no significant changes in the antioxidant defence system at either low or therapeutic doses after long-term use. Therefore, we suggest ATX could be used as a substitute for methylphenidate in the long-term treatment of ADHD.


Subject(s)
Atomoxetine Hydrochloride/pharmacology , Attention Deficit Disorder with Hyperactivity/drug therapy , Molecular Docking Simulation , Superoxide Dismutase/metabolism , Administration, Oral , Animals , Atomoxetine Hydrochloride/administration & dosage , Attention Deficit Disorder with Hyperactivity/metabolism , Brain/drug effects , Brain/enzymology , Dose-Response Relationship, Drug , Male , Molecular Structure , Rats , Rats, Wistar , Structure-Activity Relationship , Superoxide Dismutase/blood
11.
Acta Otolaryngol ; 129(10): 1101-5, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19031299

ABSTRACT

CONCLUSION: Sinusitis is accompanied by deteriorated antioxidant status, which can be alleviated with administration of cefazolin sodium or methylprednisolone. Steroids improve sinusitis when combined with antibiotics. OBJECTIVE: To evaluate the antioxidant status in response to treatment of maxillary sinusitis with methylprednisolone and cefazolin sodium. MATERIALS AND METHODS: Twenty-eight rabbits were inoculated with Staphylococcus aureus and then treated with saline, methylprednisolone, cefazolin sodium, and methylprednisolone plus cefazolin sodium, twice daily for 7 days. After the animals were sacrificed, mucosa samples were obtained to determine catalase (CAT), superoxide dismutase (SOD), and glutathione reductase (GPx) activities and levels of nitric oxide (NO) and malondialdehyde (MDA). RESULTS: Catalase activity among untreated rabbits and those treated with either methylprednisolone or cefazolin sodium was not different. Activities of SOD and GPx were lower for rabbits treated with cefazolin sodium than for those treated with methylprednisolone and for untreated rabbits (p<0.0001). Rabbits treated with cefazolin sodium had lower NO and MDA levels than those treated with methylprednisolone and untreated rabbits (p<0.0001). Combined administration of cefazolin sodium with methylprednisolone increased CAT, SOD, and GPx activities further and decreased NO and MDA levels further in comparison with their administration alone (p<0.0001).


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antioxidants/metabolism , Cefazolin/therapeutic use , Glucocorticoids/therapeutic use , Maxillary Sinusitis/drug therapy , Methylprednisolone/therapeutic use , Animals , Drug Therapy, Combination , Glucocorticoids/pharmacology , Maxillary Sinusitis/metabolism , Methylprednisolone/pharmacology , Nasal Mucosa/metabolism , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...